Concourse Financial Group Securities, Inc. Neogenomics Inc Transaction History

Concourse Financial Group Securities, Inc.

$1.64 Billion
Q3 2024

A detailed history of Concourse Financial Group Securities, Inc. transactions in Neogenomics Inc stock. As of the latest transaction made, Concourse Financial Group Securities, Inc. holds 98 shares of NEO stock, worth $1,659. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 98 -0.0%

Holding current value

$1,659

Previous $1,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 15, 2022	SELL	$7.86 - $12.91 $393 - $645	-50 Reduced 33.78%	98 $1,000
Q1 2022 May 09, 2022	SELL	$12.15 - $35.28 $4,143 - $12,030	-341 Reduced 69.73%	148 $2,000
Q3 2021 Nov 09, 2021	SELL	$41.66 - $52.52 $22,912 - $28,886	-550 Reduced 52.94%	489 $24,000
Q2 2021 Aug 13, 2021	SELL	$36.62 - $51.69 $1,830 - $2,584	-50 Reduced 4.59%	1,039 $46,000
Q1 2021 May 13, 2021	BUY	$41.56 - $59.88 $26,058 - $37,544	627 Added 135.71%	1,089 $53,000
Q4 2020 Feb 02, 2021	SELL	$36.08 - $56.47 $1,804 - $2,823	-50 Reduced 9.77%	462 $25,000
Q3 2020 Nov 13, 2020	SELL	$33.26 - $40.48 $6,652 - $8,095	-200 Reduced 28.09%	512 $19,000
Q2 2020 Aug 13, 2020	BUY	$24.21 - $31.02 $581 - $744	24 Added 3.49%	712 $22,000
Q1 2020 May 13, 2020	BUY	$20.5 - $34.53 $14,104 - $23,756	688 New	688 $19,000
Q4 2019 Feb 14, 2020	BUY	$18.96 - $29.84 $0 - $0	0 New	0 $0
Q3 2019 Nov 13, 2019	BUY	$19.12 - $26.24 $0 - $0	0 New	0 $0
Q2 2019 Aug 13, 2019	BUY	$19.57 - $24.1 $0 - $0	0 New	0 $0
Q1 2019 May 15, 2019	BUY	$12.14 - $20.46 $0 - $0	0 New	0 $0
Q4 2018 Feb 14, 2019	BUY	$11.24 - $18.5 $0 - $0	0 New	0 $0
Q3 2018 Nov 13, 2018	BUY	$12.5 - $15.38 $0 - $0	0 New	0 $0

Others Institutions Holding NEO

# of Institutions

295

Shares Held

125M

Call Options Held

698K

Put Options Held

120K

View Full List

About NEOGENOMICS INC

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $2.13B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

More about NEO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account

Concourse Financial Group Securities, Inc. Neogenomics Inc Transaction History